Cresco Labs (FRA:6CQ) Total Equity: €211.2 Mil (As of Mar. 2026)


FRA:6CQ Cresco Labs Inc FRA:6CQ
37 GF Score
Price €0.69
GF Value €0.78
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Cresco Labs Total Equity?

Cresco Labs FRA:6CQ +0.88% 37 Total Equity is €211.2 Mil as of Mar. 2026. GuruFocus rates FRA:6CQ with a GF Score™ of 37/100 and a GF Value™ of €0.78 (Modestly Undervalued). The stock has 5 warning signs investors should review.

Cresco Labs's total equity for the quarter that ended in Mar. 2026 was €211.2 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Cresco Labs Total Equity Historical Data

* Premium members only.

The historical data trend for Cresco Labs's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cresco Labs Total Equity Chart

Cresco Labs Annual Data
Trend Jan16 Jan17 Jan18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 706.00 554.77 392.54 370.71 215.64

Cresco Labs Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 347.40 312.91 289.83 215.64 211.24
FRA:6CQ
37GF Score
Cresco Labs Inc FRA:6CQ
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cresco Labs Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Cresco Labs's Total Equity for the fiscal year that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=1022.494-806.857
=215.6

Cresco Labs's Total Equity for the quarter that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=1037.013-825.771
=211.2

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of €211.2 Mil mean?
Cresco Labs (FRA:6CQ) has a Total Equity of €211.2 Mil as of Mar. 2026. The total amount of equity as record on a company's balance sheet. View historical data for Cresco Labs and its competitors.
Is Cresco Labs' Total Equity too high?
Cresco Labs' current Total Equity is €211.2 Mil. Overall, Cresco Labs has a GF Score™ of 37/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Cresco Labs' Total Equity compare to ZTS and UTHR?
Cresco Labs' Total Equity of €211.2 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Drug Manufacturers company?
A good Total Equity depends on the Drug Manufacturers industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Cresco Labs and its competitors. Cresco Labs's current Total Equity is €211.2 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cresco Labs stock overvalued right now?
Based on GuruFocus' analysis, Cresco Labs (FRA:6CQ) is currently considered Modestly Undervalued. The stock's GF Value™ is €0.78, compared to a current price of €0.69 — trading 11.5% below its estimated fair value. The current Total Equity is €211.2 Mil. Cresco Labs' overall GF Score™ is 37/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Cresco Labs (FRA:6CQ), the current Total Equity is €211.2 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cresco Labs (FRA:6CQ) Overvalued in 2026?

Based on GuruFocus' analysis, Cresco Labs stock appears to be undervalued. The current stock price of €0.69 is trading 11.5% below its estimated GF Value™ of €0.78. GuruFocus considers Cresco Labs to be Modestly Undervalued.

Key valuation signals for FRA:6CQ:

  • Total Equity: €211.2 Mil
  • GF Value™: €0.78 vs. price of €0.69 (11.5% below fair value)
  • GF Score™: 37/100 with 5 warning signs

No single metric tells the full story. See the FRA:6CQ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cresco Labs Business Description

Address 600 W. Fulton Street, Suite 800, Chicago, IL, USA, 60661
Cresco Labs Inc is a vertically-integrated multi-state cannabis operator in the United States licensed to cultivate, manufacture, and sell retail and medical cannabis products through Sunnyside, Cresco Lab's national dispensary brand, and others. The company operates in one segment: the cultivation, manufacturing, distribution, and sale of cannabis. The company's brand includes: Cresco, High Supply, FloraCal Farms, Good News, Wonder Wellness Co., Mindy's, and Remedi.
37GF Score

Get the complete analysis for FRA:6CQ

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.69
Price
€0.78
GF Value